跳至主要内容
临床试验/NCT06133231
NCT06133231招募中不适用

A Feasibility and Acceptability Study (FAST) to Optimize Research Methodology in a Multinutrient Study of Racially and Ethnically Diverse Children With ADHD and Emotional Dysregulation

Oregon Health and Science University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年1月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
Feasibility measured by count of consumed multinutrients

研究概览

简要总结

Evaluate feasibility and acceptability of recruiting Black and Hispanic families for an open label clinical trial of multinutrients while collecting real-time parent-reported child behavior data and collecting at-home biospecimens to explore their potential as biomarkers, in a study of pediatric ADHD.

详细描述

This study will test the feasibility of recruiting and completing a multinutrient trial with racially and ethnically diverse participants (N=30), focused on Black and Hispanic families, and the acceptability of the intervention, and refined collection methods. The 8-week, open-label, study will evaluate the feasibility and acceptability of collecting (a) real-time ecological momentary assessment (EMA) data on child's target behavior problem, as identified by parent and (b) two types of bio-specimens (blood and urine) collected at home while taking the multinutrients daily.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
6 Years 至 17 Years(Child)
性别
All
接受健康志愿者
否

入选标准

  • •Children, ages 6-17 years at enrollment, with suspected or definite ADHD based on parent report in a majority of families that identify as Black or Hispanic or multicultural
  • •Meet criteria on Child and Adolescent Symptom Inventory-5 (CASI-5) ADHD scale (6+ symptoms ≥ 2), occurring in >1 setting, plus one impairing irritability symptom (≥2) from Oppositional Defiant Disorder (ODD) or Disruptive Mood Dysregulation Disorder (DMDD) subscale
  • •Able and willing to swallow up to 8 pills per day
  • •Medication free for 2 weeks prior to baseline
  • •Willing to use Tasso® OnDemand SST+ to collect blood at home and filter cards to provide urine samples
  • •Able to communicate in English
  • •Parent/care giver identifies child as Black/African American or Hispanic/Latina/o or more than one race (target 70-100%)

排除标准

  • •Neurological disorders
  • •Medical conditions (e.g. cancer, kidney or liver disease, diabetes, hyperthyroidism)
  • •Psychiatric conditions requiring hospitalization
  • •Allergy to any supplement ingredient
  • •In people with a uterus: sexually active, pregnancy or suspected pregnancy
  • •Abnormality of mineral metabolism

研究组 & 干预措施

Multinutrient

Experimental

All participants will take the active multinutrient treatment

干预措施: Multinutrients; a 36-ingredient blend of vitamins, minerals, amino acids, and antioxidants (Dietary Supplement)

结局指标

主要结局

Feasibility measured by count of consumed multinutrients

时间窗: Week 4, Week 8

Feasibility will be determined based on consumption of the number of capsules determined to be beneficial based on parent and child report of symptom improvement or side effects, typically 2-4 capsules per day (up to max of 8) and achieved when greater than or equal to 75% of recommended doses have been consumed as measured at week 4 and at week 8 by pill count.

Abbreviated Acceptability Rating Profile - 7 questions on a 6-point Likert scale

时间窗: Week 8

Acceptability of taking the multinutrients will be measured through 7 questions with a 6-point Likert scale (range: Strongly Disagree to Strongly Agree). Acceptability will be achieved if greater than or equal to 70% of children and parents report that taking the capsuled multinutrients is acceptable, at or above the "Agree" range - scores of 5 or 6.

次要结局

  • Feasibility of Capillary Blood Collection(Baseline)
  • Acceptability of Capillary Blood Collection(Baseline)
  • Feasibility of Collecting 24-hour Urine(4x on one day only to reflect 24-hour urine collection - Baseline, Week 8)
  • Acceptability of Collecting 24-hour Urine(Week 8)
  • Child and Adolescent Symptom Inventory (CASI-5)(Baseline, Week 4, Week 8)
  • Clinical Global Impression - Improvement (CGI-I)(Week 4, Week 8)
  • Clinical Global Impression - Severity (CGI-S)(Baseline, Week 8)
  • Automated Self-Administered 24-Hour Dietary Assessment Tool (ASA-24)(Baseline and Week 8)
  • Parent Target Problem (PTP) using Ecological Momentary Assessment (EMA)(Baseline to Week 8, daily)
  • Feasibility of Collecting Real-Time EMA Parent Target Problem (PTP)(Week 4, Week 8)
  • Acceptability of Collecting Real-Time EMA Parent Target Problem (PTP)(Week 8)
  • Pediatric Adverse Events Rating Scale (PAERS)(Baseline, Week 4, Week 8)
  • Reasons for Dropout(Before week 7)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jeanette Johnstone

Associate Professor

National Center for Complementary and Integrative Health (NCCIH)

研究点 (1)

Loading locations...

相似试验